{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:19:58Z","timestamp":1763749198691,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012554","name":"Hubei Provincial Department of Education","doi-asserted-by":"publisher","award":["D20212001"],"award-info":[{"award-number":["D20212001"]}],"id":[{"id":"10.13039\/100012554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.111923","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T22:29:20Z","timestamp":1712010560000},"page":"111923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Geniposide alleviates imiquimod-induced psoriasis-like skin lesions in mice via inhibition of angiogenesis"],"prefix":"10.1016","volume":"132","author":[{"given":"Jiaojiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1263-5965","authenticated-orcid":false,"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5670-8313","authenticated-orcid":false,"given":"Xuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6524-4098","authenticated-orcid":false,"given":"Zhigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2024.111923_b0005","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/bjd.20963","article-title":"The biological basis of disease recurrence in psoriasis: a historical perspective and current models","volume":"186","author":"Puig","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2024.111923_b0010","first-page":"1","article-title":"Pathological angiogenesis: mechanisms and therapeutic strategies","volume":"15","author":"Dudley","year":"2023","journal-title":"Angiogenesis"},{"issue":"2","key":"10.1016\/j.intimp.2024.111923_b0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000495291","article-title":"Psoriasis: keratinocytes or immune cells \u2013 which is the trigger?","volume":"235","author":"Benhadou","year":"2019","journal-title":"Dermatology"},{"issue":"21","key":"10.1016\/j.intimp.2024.111923_b0020","doi-asserted-by":"crossref","first-page":"12035","DOI":"10.3390\/ijms222112035","article-title":"Angiogenesis in chronic inflammatory skin disorders","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.111923_b0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mehy.2016.12.003","article-title":"Cannabinoids: possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation","volume":"99","author":"Norooznezhad","year":"2017","journal-title":"Med. Hypotheses"},{"issue":"11","key":"10.1016\/j.intimp.2024.111923_b0030","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2174\/1389200219666180416162942","article-title":"Role of angiogenic growth factors in psoriasis: a review","volume":"19","author":"Akhtar","year":"2018","journal-title":"Curr. Drug. Metab."},{"issue":"6","key":"10.1016\/j.intimp.2024.111923_b0035","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4049\/jimmunol.1501138","article-title":"IL-17A contributes to the pathogenesis of endometriosis by triggering proinflammatory cytokines and angiogenic growth factors","volume":"195","author":"Ahn","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.111923_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113958","article-title":"Properties and molecular mechanisms underlying geniposide-mediated therapeutic effects in chronic inflammatory diseases","volume":"273","author":"Ran","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"14","key":"10.1016\/j.intimp.2024.111923_b0045","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1111\/bph.15046","article-title":"Direct inhibition of the TLR4\/MyD88 pathway by geniposide suppresses HIF-1\u03b1-independent VEGF expression and angiogenesis in hepatocellular carcinoma","volume":"177","author":"Zhang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.111923_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117988","article-title":"Sphingosine kinase 1\/sphingosine 1-phosphate\/sphingosine 1-phosphate receptor 1 pathway: a novel target of geniposide to inhibit angiogenesis","volume":"256","author":"Sun","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2024.111923_b0055","article-title":"CB2R deficiency exacerbates imiquimod-induced psoriasiform dermatitis and itch through the neuro-immune pathway","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2024.111923_b0060","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2024.111923_b0065","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/codi.13400","article-title":"The use of Masson's trichrome staining, second harmonic imaging and two-photon excited fluorescence of collagen in distinguishing intestinal tuberculosis from Crohn's disease","volume":"18","author":"Mao","year":"2016","journal-title":"Colorectal Dis."},{"issue":"28","key":"10.1016\/j.intimp.2024.111923_b0070","doi-asserted-by":"crossref","first-page":"12640","DOI":"10.1073\/pnas.1000132107","article-title":"Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling","volume":"107","author":"W\u00fcstehube","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.intimp.2024.111923_b0075","first-page":"10","article-title":"Expression of CD34 and CD31 in central and peripheral Giant cell granulomas","volume":"20","author":"Sadri","year":"2019","journal-title":"J. Dent (Shiraz)"},{"key":"10.1016\/j.intimp.2024.111923_b0080","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.biopha.2017.05.127","article-title":"Astilbin decreases proliferation and improves differentiation in HaCaT keratinocytes","volume":"93","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.intimp.2024.111923_b0085","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/pharmaceutics12090789","article-title":"Advanced characterization of imiquimod-induced psoriasis-like mouse model","volume":"12","author":"Jabeen","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2024.111923_b0090","doi-asserted-by":"crossref","first-page":"4925682","DOI":"10.1155\/2019\/4925682","article-title":"Diverse pharmacological activities and potential medicinal benefits of geniposide","volume":"2019","author":"Zhou","year":"2019","journal-title":"Evid. Based Complement Alternat. Med."},{"issue":"10","key":"10.1016\/j.intimp.2024.111923_b0095","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.3390\/molecules27103319","article-title":"Updated pharmacological effects, molecular mechanisms, and therapeutic potential of natural product geniposide","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.111923_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109087","article-title":"Geniposide restricts angiogenesis in experimentary arthritis via inhibiting Dnmt1-mediated PTEN hypermethylation","volume":"111","author":"Bu","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111923_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154068","article-title":"Geniposide alleviates VEGF-induced angiogenesis by inhibiting VEGFR2\/PKC\/ERK1\/2-mediated SphK1 translocation","volume":"100","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.intimp.2024.111923_b0110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaad.2015.03.041","article-title":"Angiogenesis and lymphangiogenesis in inflammatory skin disorders","volume":"73","author":"Varricchi","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.111923_b0115","first-page":"EC23","article-title":"Expression of angiogenic factors in psoriasis vulgaris","volume":"11","author":"Sankar","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.111923_b0120","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3109\/00016489.2011.652308","article-title":"Potential prognostic and therapeutic role for angiogenesis markers in laryngeal carcinoma","volume":"132","author":"Lionello","year":"2012","journal-title":"Acta Otolaryngol."},{"issue":"5","key":"10.1016\/j.intimp.2024.111923_b0125","first-page":"461","article-title":"Microvascular changes in relation to inflammation and epidermal hyperplasia in chronic cutaneous lesions of psoriasis vulgaris","volume":"32","author":"V\u00fdbohov\u00e1","year":"2017","journal-title":"Histol. Histopathol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111923_b0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/15321819.2021.1941097","article-title":"Study of serum level and immunohistochemical expression of von willebrand factor in psoriasis","volume":"43","author":"Bazid","year":"2022","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.intimp.2024.111923_b0135","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.2147\/IJN.S165966","article-title":"Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis","volume":"13","author":"Chamcheu","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.intimp.2024.111923_b0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ad.2016.12.001","article-title":"Angiogenesis in dermatology \u2013 insights of molecular mechanisms and latest developments","volume":"108","author":"Richarz","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.intimp.2024.111923_b0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.phrs.2017.11.012","article-title":"Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-\u03b1\/IFN-\u03b3-induced inflammatory response in keratinocytes and T cell-derived IL-17","volume":"129","author":"Lin","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2024.111923_b0150","doi-asserted-by":"crossref","first-page":"7624389","DOI":"10.1155\/2021\/7624389","article-title":"Cannabidiol decreases metalloproteinase activity and normalizes angiogenesis factor expression in UVB-irradiated keratinocytes from psoriatic patients","volume":"2021","author":"G\u0119gotek","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.intimp.2024.111923_b0155","article-title":"Anti-angiogenic efficacy of PSORI-CM02 and the associated mechanism in psoriasis in vitro and in vivo","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.111923_b0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/exd.13461","article-title":"TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin","volume":"27","author":"Patel","year":"2018","journal-title":"Exp. Dermatol."},{"issue":"8","key":"10.1016\/j.intimp.2024.111923_b0165","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/exd.14151","article-title":"Vascular endothelial growth factor-A as a promising therapeutic target for the management of psoriasis","volume":"29","author":"Luengas-Martinez","year":"2020","journal-title":"Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2024.111923_b0170","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/exd.14790","article-title":"Topical application of imatinib mesylate ameliorated psoriasis-like skin lesions in imiquimod-induced murine model via angiogenesis inhibition","volume":"32","author":"Hayakawa","year":"2023","journal-title":"Exp. Dermatol."},{"issue":"98","key":"10.1016\/j.intimp.2024.111923_b0175","first-page":"97","article-title":"Targeting VEGF\/VEGFR in the treatment of psoriasis","volume":"18","author":"Li","year":"2014","journal-title":"Discov. Med."},{"key":"10.1016\/j.intimp.2024.111923_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108129","article-title":"Nintedanib ameliorates imiquimod-induced psoriasis in mice by inhibiting NF-\u03baB and VEGFR2 signaling","volume":"100","author":"Li","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111923_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175276","article-title":"Inhibition of JAK1\/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model","volume":"933","author":"Tang","year":"2022","journal-title":"Eur. J. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924004417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924004417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T04:00:30Z","timestamp":1719979230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924004417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":37,"alternative-id":["S1567576924004417"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111923","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geniposide alleviates imiquimod-induced psoriasis-like skin lesions in mice via inhibition of angiogenesis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111923"}}